Most Active Stories
- Non-Verbal & Non-Linear, Jill Burton’s Singing Creates Spontaneous Soundscapes
- Choral Arts of Chattanooga Presents 'Wonderful Peace' Holiday Concert 12/13
- 'A Christmas Story, The Musical' Adds New Depth to Beloved Characters
- Give a meaningful gift through WUTC
- UTC recognized by U.S. News and World Report for work with student veterans
Novartis Loses Patent Battle In India
Originally published on Fri April 5, 2013 8:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.